Clinical Trial Update: The Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib Vaccine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing immediate and long-term immune responses to a Hib booster dose in infants and young children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Disease

Drugs mentioned

• Hib vaccine (Haemophilus influenzae type b vaccine)

Snippet

Sponsor: Public Health England | Conditions: Haemophilus Influenzae Type b | Phase 4 | Status: COMPLETED